Medical Devices Australia

Australia Glaucoma Surgery Devices Market Analysis, 2024–2034

Australia Glaucoma Surgery Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $13.8 Mn Estimated value
Estimate 2025 $15.2 Mn 1.1% of the global market
Projected 2034 $37.1 Mn 143.6% Adds $21.9 Mn over 9 forecast years
CAGR 2025–2034 10.4% Faster than 51% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.07% of the global market.
  • In APAC, the largest is China at $132.6 Mn.
  • Fastest growing: India at 11.9% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$21.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Glaucoma Surgery Devices Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $13.8 Mn — —
2025 (base) $15.2 Mn +$1.4 Mn —
2026 (forecast) $16.8 Mn +$1.6 Mn +10.4%
2027 (forecast) $18.6 Mn +$1.7 Mn +21.9%
2028 (forecast) $20.5 Mn +$1.9 Mn +34.6%
2029 (forecast) $22.6 Mn +$2.1 Mn +48.6%
2030 (forecast) $25.0 Mn +$2.4 Mn +64%
2031 (forecast) $27.6 Mn +$2.6 Mn +81.1%
2032 (forecast) $30.5 Mn +$2.9 Mn +99.9%
2033 (forecast) $33.6 Mn +$3.2 Mn +120.7%
2034 (forecast) $37.1 Mn +$3.5 Mn +143.6%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.43 Bn
  2. North America $672.0 Mn
  3. US $658.8 Mn
  4. APAC $348.5 Mn
  5. Europe $276.5 Mn
  6. China $132.6 Mn
  7. Canada $126.1 Mn
  8. Japan $82.3 Mn
  9. Latin America $73.2 Mn
  10. Middle East $62.1 Mn
  11. Germany $53.1 Mn
  12. France $41.9 Mn
  13. Brazil $39.6 Mn
  14. Italy $35.8 Mn
  15. UK $32.6 Mn
  16. Ecuador $29.6 Mn
  17. India $28.8 Mn
  18. Spain $26.4 Mn
  19. Saudi Arabia $22.9 Mn
  20. Mexico $19.0 Mn
  21. Africa $19.4 Mn
  22. Russia $16.0 Mn
  23. Australia (this report) $15.2 Mn
  24. New Zealand $12.2 Mn
  25. South Africa $8.4 Mn
  26. UAE $8.0 Mn
  27. Egypt $3.8 Mn
  28. Philippines $3.2 Mn
  29. Hong Kong $2.5 Mn
  30. Malaysia $2.3 Mn
  31. Thailand $1.9 Mn
  32. Singapore $1.7 Mn
  33. Kenya $1.0 Mn

The Australia Glaucoma Surgery Devices Market Analysis Executive Summary

Glaucoma surgery devices lower eye pressure using tiny stents, shunts and lasers, often during cataract surgery.

Key segments of the glaucoma Surgery Devices market include product (MIGS Devices, Glaucoma Drainage Devices and Laser Systems) and procedure (Standalone and Combined with Cataract Surgery).

Australia Glaucoma Surgery Devices Market Dynamics

Market Growth Drivers

An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.

Opportunity

Longer-acting treatments, home-based care and screening in emerging markets give the glaucoma Surgery Devices market room to grow.

Market Restraints

High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the glaucoma Surgery Devices market.

Competitive Landscape for Glaucoma Surgery Devices Market in Australia

The glaucoma Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Glaucoma Surgery Devices Market in Australia

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how glaucoma Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Glaucoma Surgery Devices right now, from free public sources.

Clinical trials

4 active trials in Australia

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. SpyGlass Pharma, Inc. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  2. iSTAR Medical 5 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Glaukos 4 active trials on ClinicalTrials.gov (opens in a new tab)
  4. AbbVie Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. VividWhite Pty Ltd 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 916 papers since 2021 (worldwide)

  1. Selective Laser Trabeculoplasty in Advanced-to-Severe Primary Open-Angle Glaucoma: Six-Month Clinical Outcomes. Cureus, 2026
  2. Patient-Reported Outcomes After Glaucoma Surgery: A Narrative Review for Clinical Decision-Making. Clinical ophthalmology (Auckland, N.Z.), 2026
  3. Incidence and Management of Ocular Hypertension Following the 0.19 mg Fluocinolone Acetonide Implant for Diabetic Macular Edema. Retina (Philadelphia, Pa.), 2026
  4. Late-onset filtering bleb complications: A review. Survey of ophthalmology, 2026
  5. Ab-interno Ripcord Reinsertion for Overfiltration-related Hypotony After A-stream Glaucoma Shunt Surgery. Korean journal of ophthalmology : KJO, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Glaucoma Surgery Devices in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How many clinical trials on Glaucoma Surgery Devices are running in Australia?
4 studies are recruiting, active or about to start in Australia.[4]
How much research is published on Glaucoma Surgery Devices?
PubMed lists 916 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Glaucoma Surgery Devices in Australia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Australia

See all
Same topic, other categories

Related on eye health

See the topic